An Microbial Therapeutic kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans. Therapies that kill microorganisms are called microbiocidal therapies and therapies that only inhibit the growth of microorganisms are called microbiostatic therapies.
This report contains market size and forecasts of Microbial Therapeutic Products in Global, including the following market information:
Global Microbial Therapeutic Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Microbial Therapeutic Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bacteria Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Microbial Therapeutic Products include Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi SA, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Abbott Laboratories and Amgen Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microbial Therapeutic Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microbial Therapeutic Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Microbial Therapeutic Products Market Segment Percentages, by Type, 2021 (%)
Bacteria
Fungi
Others
Global Microbial Therapeutic Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Microbial Therapeutic Products Market Segment Percentages, by Application, 2021 (%)
Hospitals
Pharmaceuticals & Biopharmaceutical Companies
Research & academic institutions
Global Microbial Therapeutic Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Microbial Therapeutic Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microbial Therapeutic Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Microbial Therapeutic Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy’s Laboratories
Pfizer Inc.
Sanofi SA
Merck & Co. Inc.
Novartis AG
Novo Nordisk A/S
Abbott Laboratories
Amgen Inc